McDermott Will & Emery LLP
Roger Kuan focuses his practice on intellectual property procurement/portfolio management, IP transactions and strategic IP counseling for clients in the personalized/precision medicine (e.g., genomic sequencing platforms, computational genomics/bioinformatics, molecular diagnostics, etc.), digital health, life sciences tooling (e.g., biomanufacturing, analytical instrumentation, flow cytometry, etc.), medical device and chemical industries. He has extensive experience in intellectual property strategy and management, preparation and prosecution (utility/design patents, trademarks and trade dress), counseling and litigation, licensing and technology transactions, freedom-to-operate clearances, monetization, IP due diligence, IP risk recognition and mitigation, and dispute resolution.
He served as Director IP Counsel at a multinational biotechnology company, where he managed a team of lawyers and agents to support the worldwide IP needs of the company’s life sciences tooling, bio production/bio manufacturing, molecular diagnostics, and nucleic acid sequencing product platforms. Roger worked in the life sciences industry for several Fortune 500 pharmaceutical, medical device, and chemical companies. He held professional positions in the R&D, sales, engineering, and regulatory affairs organizations.